Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vanderbilt University Medical Center

Division of Vanderbilt University

Latest From Vanderbilt University Medical Center

New CMS Lab Test Panel Meets To Make Payment Policy Recommendations

The Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests held its inaugural meeting Aug. 26 to begin work on recommending crosswalks and gapfills for more than 25 molecular tests codes.

Medical Device Reimbursement

TYRX Gains FDA Clearance For Resorbable Antibacterial Device Envelope

TYRX Inc. has received FDA clearance for a fully-resorbable version of its antibacterial envelope, used to prevent surgical site infections in patients who receive implantable devices such as ICDs. The resorbable device has important advantages over the previous durable envelope and could substantially boost physician adoption of the company’s technology.

Medical Device

Pursuit Of R&D Efficiency Continues As Regulatory Options Expand In 2013 – Tufts CSDD

Cutting non-core procedures – such as those supporting exploratory endpoints – from study budgets could save the industry $6 billion a year in drug development costs, the Tufts Center for the Study of Drug Development suggests in its 2013 industry outlook report.

BioPharmaceutical Advertising, Marketing & Sales

Deals Of The Week: AstraZeneca/Vanderbilt, Medicago, OcellO/Merus

High-level executive changes at AstraZeneca continue pondering of where the British pharma turns next for growth – will it look to large-scale M&A again?

BioPharmaceutical Deals
See All